Mr Mrs Miss Ms Dr Other

Dr
Owain
Summers

Patent Director

York Office

Technology & Engineering

Telephone. +44(0) 1904 732 120
Email. osummers@hgf.com
UPC Representative
Our team of specialist European patent litigators, oppositions specialists and patent attorneys bring together an extensive depth of legal and technical knowledge and are qualified to represent you in the UPC.
Vcard
Linkedin

Experience

With a background in theoretical physics, Owain has expertise in the fields of physics, electronics and telecommunications, with a particular focus on user equipment, base stations, computer software and 3GPP-related telecommunications standards including 3G, LTE, LTE-A, 4G and 5G (NR).

In addition to having drafted patent applications in these fields, he has significant experience of patent application prosecution at the European Patent Office, including having represented clients at numerous examination Oral Proceedings at the EPO. Owain has also prosecuted patent applications at the UK IPO and worked on oppositions at the EPO.

Owain entered the patent profession in 2013, joining HGF at their York office. In 2016, he qualified as a European Patent Attorney and a Chartered Patent Attorney.

Specialisms

Industries

Services

Qualifications

Patent Attorney

Chartered (UK)
Europe

MPHYS

MPhys in Theoretical Physics

PHD

in Physics

POSTGRADUATE DIPLOMA OR CERTIFICATE

Postgraduate Certificate in Intellectual Property

Publications

Exam Success!

View publication online

CSR

Owain has mentored junior colleagues to assist in their preparation for the European Qualifying Examinations, and has also acted as a tutor to assist in preparation for the European Qualifying Examinations and UK final Qualifying Examinations for a Patent Attorney.

Related News

PRESS RELEASE – HGF strengthens European presence with three new Partners in France and Germany

HGF is pleased to announce the arrival of three new partners, further strengthening its European presence. Two partners will be joining the firm’s fast-growing French practice, and one will join …

Read article

G1/23: The Enlarged Board of Appeal shift EPO practice towards an “on-sale” bar.

Last week, the EPO’s Enlarged Board of Appeal (EBA) issued its Decision that both a product put on the market before the date of filing of a European patent application, …

Read article

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

Often Copied, Never Equaled: When Do Everyday Items Become Subject of Copyright?

The  borderline between ‘pure’ works of art and mere utilitarian objects” –  Can iconic, yet everyday products be protected under copyright? The above question was posed by Advocate General in …

Read article

T 0883/23: Dosage claims and their entitlement to priority when only the clinical trial protocol was disclosed in the priority application

In a recently issued decision by the EPO’s Board of Appeal (BoA), the BoA held that claims directed to a combination of active pharmaceutical ingredients (APIs) at particular doses were …

Read article

The end of the Brexit overhang for trade marks: review, refile and revoke.

On the 31st December 2025, five years will have passed since the end of the Brexit transitional period on 31st December 2020. Why is this relevant? For UK cloned trade …

Read article
Event - 14th January 2026

Seminar on The aftermath of G1/24 - has anything changed?

HGF is hosting a The aftermath of G1/24 – has anything changed? Which will be followed by networking, apero, and snacks. The Seminar will be held on Wednesday, 14th January …

Event details
See all updates

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.

Contact us